AU2003281268A1 - Cephalosporin preparation for oral use - Google Patents

Cephalosporin preparation for oral use

Info

Publication number
AU2003281268A1
AU2003281268A1 AU2003281268A AU2003281268A AU2003281268A1 AU 2003281268 A1 AU2003281268 A1 AU 2003281268A1 AU 2003281268 A AU2003281268 A AU 2003281268A AU 2003281268 A AU2003281268 A AU 2003281268A AU 2003281268 A1 AU2003281268 A1 AU 2003281268A1
Authority
AU
Australia
Prior art keywords
oral use
cephalosporin preparation
cephalosporin
preparation
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003281268A
Inventor
Kenji Hamaura
Hiroshi Yamakose
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU2003281268A1 publication Critical patent/AU2003281268A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003281268A 2002-07-08 2003-07-08 Cephalosporin preparation for oral use Abandoned AU2003281268A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002198464 2002-07-08
JP2002-198464 2002-07-08
PCT/JP2003/008673 WO2004004737A1 (en) 2002-07-08 2003-07-08 Cephalosporin preparation for oral use

Publications (1)

Publication Number Publication Date
AU2003281268A1 true AU2003281268A1 (en) 2004-01-23

Family

ID=30112427

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003281268A Abandoned AU2003281268A1 (en) 2002-07-08 2003-07-08 Cephalosporin preparation for oral use

Country Status (3)

Country Link
AU (1) AU2003281268A1 (en)
TW (1) TW200404550A (en)
WO (1) WO2004004737A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5173190B2 (en) 2004-08-25 2013-03-27 武田薬品工業株式会社 Preventive and therapeutic agent for stress urinary incontinence and screening method thereof
US20070134277A1 (en) * 2005-12-09 2007-06-14 Children's Medical Center Corporation Pharmaceutical formulation for sulfur-containing drugs in liquid dosage forms
WO2011139251A1 (en) * 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical compositions comprising cefditoren pivoxil
CN102370621A (en) * 2010-08-19 2012-03-14 北京润德康医药技术有限公司 Solid preparation with cefotiam hexetil as active component
TR201007106A1 (en) * 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Cefpodoxime proxetil formulations.
TR201007107A1 (en) * 2010-08-25 2012-03-21 Bi̇lgi̇ç Mahmut Formulations of cefpodoxime proxetil containing taste regulating agent.
TR201009168A2 (en) * 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Water dispersible cefpodoxime proxetil formulations.
CN103479589B (en) * 2013-09-22 2016-04-13 海南葫芦娃制药有限公司 cefpodoxime proxetil dispersible tablet and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418957A1 (en) * 1994-05-31 1995-12-07 Merck Patent Gmbh Cefixime preparation
ES2079327B1 (en) * 1994-12-13 1996-08-01 Lilly Sa PHARMACEUTICAL FORMULATIONS OF CEFACLOR.
DE69712332T2 (en) * 1996-02-29 2002-10-02 Fujisawa Pharmaceutical Co TABLETS CONTAINING BETA LACTAM ANTIBIOTIC AND METHOD FOR THE PRODUCTION THEREOF
US6080427A (en) * 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
AT413647B (en) * 1998-11-26 2006-04-15 Sandoz Ag USE OF A COPOLYMERISATE OF 1-VINYL-2-PYRROLIDONE AND VINYL ACETATE FOR THE PREPARATION OF CEFUROXIMAXETIL-SUBJECTED TABLETS
AT500063A1 (en) * 1999-11-23 2005-10-15 Sandoz Ag COATED TABLETS

Also Published As

Publication number Publication date
WO2004004737A1 (en) 2004-01-15
TW200404550A (en) 2004-04-01

Similar Documents

Publication Publication Date Title
AU2003225444A1 (en) Oral suspension formulation
AU2003303518A1 (en) Hand held oral irrigator
AU2003245700A1 (en) Pyrazolopyridine derivatives
AU2003300958A1 (en) Water-soluble film for oral use
AU2003294536A1 (en) Dental handpiece
AU2003301424A1 (en) Perfluoropolyether derivatives
HK1085131A1 (en) Solid drug for oral use
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003226189A1 (en) Oral administration of epothilones
AU2003252722A1 (en) Toothbrush
AU2003252694A1 (en) External preparation
AU2003290436A1 (en) Oral preparation system
AU2003252683A1 (en) Composition for oral use
AU2003284356A1 (en) Double dental mirror
AU2002952355A0 (en) Cephem compounds
AU2003281268A1 (en) Cephalosporin preparation for oral use
AU2003269617A1 (en) Dental floss
AU2003284460A1 (en) Medicinal composition
AU2003297469A1 (en) Twin-headed toothbrush
EP1614417A4 (en) Solid preparation for oral use
AU2003264443A1 (en) Preparation for external use
AU2003280799A1 (en) Medicinal composition
AU2003298683A1 (en) Cable-testing adapter
AU2002258241A1 (en) Toothbrush
AU2003229604A1 (en) Disposable toothbrush

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase